Skip to content

Blood Pressure Management in the Care Home Population

Describing the Management of Hypertension in a UK Care Home Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06337682
Acronym
BPITCH
Enrollment
3000
Registered
2024-03-29
Start date
2016-01-31
Completion date
2024-06-30
Last updated
2024-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Hypertension

Keywords

Nursing Home, Residential Home, Deprescribing

Brief summary

The UK care home population is projected to increase significantly over the coming decades. A high proportion of individuals in a care home have multiple long-term conditions and take large amounts of prescribed medication. This means they are routinely excluded from research studies and so there is little evidence on which to base treatment of long-term conditions such as high blood pressure. Furthermore, given that 1 in 4 people admitted into a care home die within 1 year, the benefit of treating high blood pressure to reduce the risk of heart attack or stroke must be balanced with the need to optimise quality of life. The aim of this study is to describe the health and social characteristics of the UK care home population with a particular focus on the management of blood pressure in the population. It is hoped that the findings of this study will help inform future research into the management of chronic conditions in care home residents.

Detailed description

The investigators will use the connected Bradford dataset to examine UK electronic health records to describe the UK care home population and management of hypertension in this population. The sample will include all adults aged 65 and over who have been admitted into a care home between January 2016 and December 2019. The investigators will extract data at the time of care home admission including age, sex, ethnicity, coded diagnosis of hypertension, indices of frailty and risk of falls as well as comorbidities relevant to cardiovascular risk and falls risk. Analysis will include looking at the prevalence of hypertension amongst the care home population, describing treatment patterns (i.e. number and type of prescribed anti-hypertensive medications, frequency of blood pressure monitoring) and the proportion of patients with blood pressure controlled according to National Institute of Health and Care Excellence (NICE) guidelines. The investigators will also look to establish whether there are any changes in the number and type of prescribed antihypertensive medication before and after admission to a care home (i.e. intensification of pharmacological therapy or deprescribing) and whether this differs amongst different subgroups of populations including patients with terminal illness and stroke diagnosis. The investigators will also estimate frequency of falls in the year following care home admission.

Interventions

None listed

Sponsors

Bradford Teaching Hospitals NHS Foundation Trust
CollaboratorOTHER_GOV
University of Leeds
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum

Inclusion criteria

* registered to a GP practice contributing to the Connected Bradford dataset at the point of admission * a recorded length of stay in a care home of longer than six weeks * recorded social care entry for nursing or residential care in the Bradford council social care data.

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
Injurious fallsfrom the point of admission up to 12 months after admissionone year incidence of a fall resulting in hospital attendance in those entering a care home
Frequency of blood pressure measurementsfrom the point of admission up to 12 months following admissionthe proportion of individuals entering a care home, with a diagnosis of hypertension, have their blood pressure measured in the year following admission
change in antihypertensive medication6 months before admission to 6 months following admissionchange in the number or type of antihypertensive mediation from six months before care home admission to six months following care home admission

Secondary

MeasureTime frameDescription
Blood pressure treatment12 months following admissionof those with a diagnosis of hypertension and a blood pressure value recorded in the 12 months after admission, proportion a blood pressure value below the target set by the National Institute for Health and Care Excellence (i.e. for those aged 80 and over 150/90 and those aged below 80 years 140/90)
Prevalence of hypertensionat the day of admission to a care home (this will vary between each individual)the proportion of individuals in the care home cohort with a diagnosis of hypertension at the point of care home admission
Antihypertensive medicationat the day of admission to a care home (this will vary between each individual)the number and type of antihypertensive medication prescribed at the point of admission

Other

MeasureTime frameDescription
change in systolic pressure following care home admission12 months before admission for the first measure and 12 months after admission for the second measure.the difference between systolic blood pressure recorded before care home admission (defined as less than 12 months for care home admission) and systolic blood pressure recorded after care home admission (blood pressure recorded within 12 months following admission)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026